The FISH - NTRK 1 Gene Rearrangement Assay Test is a specialized diagnostic procedure aimed at detecting rearrangements in the NTRK1 gene. This test is crucial for identifying specific genetic alterations that may influence the behavior of certain cancers, thereby guiding tailored treatment options. The Fluorescence In Situ Hybridization (FISH) technique is utilized in this assay to visualize and map out the genetic changes in chromosomes, particularly focusing on the NTRK1 gene, which can play a significant role in tumor development and progression.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test offers a sophisticated level of diagnostic insight that can be pivotal for patients with cancers that may respond to targeted therapies. The cost of the test is set at 1400 AED, reflecting the intricate technology and expertise required to accurately identify NTRK1 gene rearrangements.
By opting for this test, patients and healthcare providers can make more informed decisions regarding treatment strategies, potentially leading to better outcomes through personalized medicine approaches.
The FISH (Fluorescence In Situ Hybridization) - NTRK 2 Gene Rearrangement Assay Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect rearrangements involving the NTRK2 gene. This test employs the FISH technique, a powerful molecular cytogenetic method that uses fluorescent probes to visualize and map the genetic material in an individual's cells, specifically targeting the NTRK2 gene to identify any structural changes.
NTRK2 gene rearrangements are critical to identify because they can play a significant role in the development and progression of various types of cancer. The presence of these rearrangements can influence treatment decisions, as certain targeted therapies are more effective in tumors with NTRK gene fusions.
The test is priced at 1400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE. By providing this service, DNA Labs UAE supports the precise diagnosis and personalized treatment planning for patients with tumors that may harbor NTRK gene rearrangements, contributing to more tailored and effective cancer care.
The FISH (Fluorescence In Situ Hybridization) - NTRK 3 Gene Rearrangement Assay Test is a sophisticated diagnostic procedure designed to identify rearrangements involving the NTRK3 gene. This gene plays a critical role in the development and function of the nervous system, and its rearrangements can lead to various types of cancer, including certain sarcomas, breast cancer, and thyroid cancer. The test utilizes fluorescent probes to visualize the presence or absence of specific genetic alterations directly within the chromosomes of cells extracted from a patient's tissue sample. This targeted approach allows for a high degree of specificity and sensitivity in detecting NTRK3 gene rearrangements.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test is available for a cost of 1400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. The FISH - NTRK 3 Gene Rearrangement Assay Test is crucial for patients suspected of having cancers that may involve NTRK3 gene alterations, as it can provide essential information for diagnosis, prognosis, and determining the most effective treatment strategy, including the possibility of targeted therapy.
The Gabapentin Test is a specialized diagnostic procedure aimed at detecting and measuring the levels of Gabapentin in the body. Gabapentin, a medication commonly prescribed for the management of neuropathic pain, seizures, and other conditions, requires careful monitoring to ensure therapeutic efficacy and avoid potential side effects. The test is particularly relevant for individuals undergoing treatment with Gabapentin, enabling healthcare providers to tailor dosages accurately and optimize treatment plans.
Conducted at DNA Labs UAE, a leading facility renowned for its advanced diagnostic services and adherence to international standards, the Gabapentin Test ensures precision and reliability. The test cost is set at 1400 AED, reflecting the sophisticated technology and expertise involved in the analysis. By choosing DNA Labs UAE for the Gabapentin Test, patients and healthcare providers can expect comprehensive support, from sample collection to detailed result interpretation, facilitating effective management of conditions requiring Gabapentin therapy.
The "HAINS Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test" is a sophisticated diagnostic assessment offered by DNA Labs UAE, designed to detect resistance to both first and second-line anti-tuberculosis drugs. This test is crucial for tailoring the most effective treatment plans for individuals diagnosed with tuberculosis (TB), a contagious bacterial infection caused by Mycobacterium tuberculosis. By identifying specific genetic mutations associated with drug resistance, healthcare providers can make informed decisions on the most suitable medications, thus improving treatment outcomes and reducing the risk of further resistance development. The test is priced at 1400 AED, reflecting the advanced technology and expertise required to perform this comprehensive analysis. It represents a significant step forward in the fight against TB, particularly in cases where drug resistance poses a major treatment challenge.
The "Hair Transplant Panel B with COVID Antibodies Test" is a comprehensive diagnostic package offered by DNA Labs UAE, tailored for individuals considering hair transplantation while also assessing their COVID-19 antibody status. Priced at 1400 AED, this test panel is designed to ensure that candidates for hair transplant procedures are not only suitable for the surgery but are also evaluated for their immunity against COVID-19, which is crucial in the current pandemic scenario.
This dual-purpose test serves an essential role in pre-surgical planning by providing critical health information. The Hair Transplant Panel part of the test evaluates various factors that could affect the success of a hair transplant, such as hormonal levels and other markers important for hair growth and scalp health. Concurrently, the COVID Antibodies Test component measures the presence of antibodies against the SARS-CoV-2 virus, indicating past exposure to the virus and potentially offering insights into the patient's immune response.
Administered at the state-of-the-art facilities of DNA Labs UAE, this combined test ensures a holistic approach to patient care, addressing both the specific needs related to hair transplantation and the broader health considerations in light of the ongoing pandemic. The inclusion of the COVID-19 antibodies test adds an extra layer of safety for both patients and medical staff by identifying individuals who may have developed an immune response to the virus, thereby facilitating safer surgical environments and optimized patient care pathways.
The HLA Hypersensitivity to Abacavir B*5701 Test is a genetic screening designed to identify individuals who are at risk of developing a hypersensitivity reaction to abacavir, a medication commonly used in the treatment of HIV. This hypersensitivity reaction can be severe and potentially life-threatening, making it crucial to identify at-risk individuals before the initiation of abacavir treatment.
The test specifically looks for the presence of the HLA-B*5701 allele, a genetic variant strongly associated with an increased risk of abacavir hypersensitivity. By detecting this allele, healthcare providers can make informed decisions regarding the suitability of abacavir for their patients, thus significantly reducing the risk of adverse reactions.
Offered at DNA Labs UAE, the HLA Hypersensitivity to Abacavir B*5701 Test is priced at 1400 AED. Conducted in a state-of-the-art laboratory setting, the test provides accurate and reliable results, ensuring that patients receive the safest and most effective care tailored to their genetic profile.
The HLA Hypersensitivity to Allopurinol B*5801 Test is a specialized diagnostic assessment designed to identify individuals at increased risk of developing severe adverse reactions to allopurinol, a medication commonly used to treat gout and certain types of kidney stones. This test is particularly crucial as it screens for the presence of the HLA-B*5801 allele, a genetic variant associated with a heightened sensitivity to allopurinol, leading to potentially life-threatening conditions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Conducted at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test ensures precision and reliability in results. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for the specific HLA-B*5801 allele. The presence of this allele can significantly influence the course of treatment for individuals requiring allopurinol, guiding healthcare providers to consider alternative medications or adjust dosages accordingly to mitigate the risk of severe reactions.
The cost of the HLA Hypersensitivity to Allopurinol B*5801 Test at DNA Labs UAE is 1400 AED, an investment in personalized medicine that can greatly enhance patient safety and treatment efficacy. By identifying genetic predispositions to drug hypersensitivity, this test represents a critical step forward in the field of pharmacogenomics, offering a tailored approach to medication management and reducing the likelihood of adverse drug reactions.
The HLA Hypersensitivity to Carbamazepine and Phenytoin B*1502 Test is a specialized diagnostic assessment designed to identify individuals who are at an increased risk of developing severe hypersensitivity reactions to the anticonvulsant medications carbamazepine and phenytoin. This test is particularly crucial for patients who are being considered for therapy with these drugs, as it helps in guiding clinicians to make safer prescription choices. The test works by detecting the presence of the HLA-B*1502 allele, a genetic marker strongly associated with an increased risk of adverse reactions to these medications in certain populations, particularly those of Asian descent.
Conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing services, the test ensures accuracy and reliability in results. The cost of the HLA Hypersensitivity to Carbamazepine and Phenytoin B*1502 Test is 1400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. This test represents a crucial step towards personalized medicine, enabling healthcare providers to tailor treatments to the genetic profiles of their patients, thus minimizing the risk of drug-induced hypersensitivity reactions and enhancing patient safety.
The "Immunosuppressant Drug Profile 3 Test" is a specialized medical test designed to monitor and measure the levels of specific immunosuppressive drugs in the bloodstream. This test is particularly important for individuals who have undergone organ transplantation or are being treated for autoimmune diseases, as it helps in ensuring that the dosage of immunosuppressant medications is optimal to prevent organ rejection while minimizing potential side effects. The test can analyze the concentration of various immunosuppressant drugs, aiding healthcare providers in adjusting medication dosages for effective treatment management.
Performed at DNA Labs UAE, a reputable laboratory known for its advanced diagnostic solutions and accurate testing services, this test offers a reliable assessment for patients undergoing immunosuppressive therapy. The cost of the "Immunosuppressant Drug Profile 3 Test" is set at 1400 AED, reflecting the sophisticated nature of the analysis and the valuable insights it provides for personalized patient care. By availing of this test at DNA Labs UAE, patients and healthcare providers can work together more effectively to manage complex conditions requiring immunosuppression, ensuring better health outcomes and improved quality of life.
